These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2338658)
21. Morphine effects on locus ceruleus neurons are dependent on the state of arousal and availability of external stimuli: studies in anesthetized and unanesthetized rats. Valentino RJ; Wehby RG J Pharmacol Exp Ther; 1988 Mar; 244(3):1178-86. PubMed ID: 3252031 [TBL] [Abstract][Full Text] [Related]
22. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy. Gordon JT; Tomlinson EE; Greenberg J; Dratman MB J Pharmacol Exp Ther; 1994 Jul; 270(1):111-7. PubMed ID: 8035306 [TBL] [Abstract][Full Text] [Related]
23. Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress. Valentino RJ; Wehby RG Neuroendocrinology; 1988 Dec; 48(6):674-7. PubMed ID: 2908000 [TBL] [Abstract][Full Text] [Related]
24. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Reyes BA; Fox K; Valentino RJ; Van Bockstaele EJ Eur J Neurosci; 2006 Jun; 23(11):2991-8. PubMed ID: 16819988 [TBL] [Abstract][Full Text] [Related]
25. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013 [TBL] [Abstract][Full Text] [Related]
26. Sertraline: a new antidepressant. Doogan DP; Caillard V J Clin Psychiatry; 1988 Aug; 49 Suppl():46-51. PubMed ID: 2842321 [TBL] [Abstract][Full Text] [Related]
27. Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Curtis AL; Bethea T; Valentino RJ Neuropsychopharmacology; 2006 Mar; 31(3):544-54. PubMed ID: 16123744 [TBL] [Abstract][Full Text] [Related]
28. The role of corticotropin-releasing factor in the pathogenesis of major depression. Nemeroff CB Pharmacopsychiatry; 1988 Mar; 21(2):76-82. PubMed ID: 3293091 [TBL] [Abstract][Full Text] [Related]
29. Regulation of a putative neurotransmitter effect of corticotropin-releasing factor: effects of adrenalectomy. Pavcovich LA; Valentino RJ J Neurosci; 1997 Jan; 17(1):401-8. PubMed ID: 8987765 [TBL] [Abstract][Full Text] [Related]
30. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats. Wilson MA; Biscardi R; Smith MD; Wilson SP J Pharmacol Exp Ther; 1996 Sep; 278(3):1073-82. PubMed ID: 8819488 [TBL] [Abstract][Full Text] [Related]
31. Effects of chronic and acute stressors and CRF on depression-like behavior in mice. Swiergiel AH; Leskov IL; Dunn AJ Behav Brain Res; 2008 Jan; 186(1):32-40. PubMed ID: 17716752 [TBL] [Abstract][Full Text] [Related]
32. Cellular interactions between axon terminals containing endogenous opioid peptides or corticotropin-releasing factor in the rat locus coeruleus and surrounding dorsal pontine tegmentum. Tjoumakaris SI; Rudoy C; Peoples J; Valentino RJ; Van Bockstaele EJ J Comp Neurol; 2003 Nov; 466(4):445-56. PubMed ID: 14566941 [TBL] [Abstract][Full Text] [Related]
33. Pilocarpine-induced convulsions in rats: evidence for muscarinic receptor-mediated activation of locus coeruleus and norepinephrine release in cholinolytic seizure development. el-Etri MM; Ennis M; Jiang M; Shipley MT Exp Neurol; 1993 May; 121(1):24-39. PubMed ID: 7684335 [TBL] [Abstract][Full Text] [Related]
34. REM sleep suppression by monoamine reuptake blockade: development of tolerance with repeated drug administration. Ross RJ; Ball WA; Gresch PJ; Morrison AR Biol Psychiatry; 1990 Aug; 28(3):231-9. PubMed ID: 2165825 [TBL] [Abstract][Full Text] [Related]
35. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Bondi CO; Barrera G; Lapiz MD; Bedard T; Mahan A; Morilak DA Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):482-95. PubMed ID: 17188790 [TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing factor promotes growth of brain norepinephrine neuronal processes through Rho GTPase regulators of the actin cytoskeleton in rat. Swinny JD; Valentino RJ Eur J Neurosci; 2006 Nov; 24(9):2481-90. PubMed ID: 17100837 [TBL] [Abstract][Full Text] [Related]
37. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. Valentino RJ; Foote SL J Neurosci; 1988 Mar; 8(3):1016-25. PubMed ID: 3258021 [TBL] [Abstract][Full Text] [Related]
38. Studies on the locus coeruleus system in an animal model for antidepressive activity. Kostowski W; Danysz W; Płaźnik A; Nowakowska E Pol J Pharmacol Pharm; 1984; 36(5):523-30. PubMed ID: 6099890 [TBL] [Abstract][Full Text] [Related]
39. Effects of intracerebroventricular corticotropin releasing factor on sensory-evoked responses in the rat visual thalamus. Zitnik GA; Clark BD; Waterhouse BD Brain Res; 2014 May; 1561():35-47. PubMed ID: 24661913 [TBL] [Abstract][Full Text] [Related]
40. DMI-induced sexual effects in male rats: analysis of DMI's acute and chronic actions on copulatory behavior and on the genital motor pattern of ejaculation. Hueletl-Soto ME; Carro-Juárez M; Rodríguez-Manzo G Pharmacol Biochem Behav; 2010 Jan; 94(3):423-30. PubMed ID: 19850062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]